Indeed, the treatment of Plasmodium-infected mice with neutralising antibodies to TGF-β exacerbated the malaria disease [4], while IL-9 played a protective role during experimental chronic infection with T. cruzi by reducing parasite multiplication and invasion [38]. The gene discussed is TGFB1; the disease is malaria.